CATALOGO DEI PRODOTTI DELLA RICERCA

BENEDETTI, MARIADONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.006
EU - Europa 4.891
AS - Asia 3.441
SA - Sud America 435
Continente sconosciuto - Info sul continente non disponibili 107
AF - Africa 79
OC - Oceania 12
Totale 14.971
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.913
RU - Federazione Russa 1.817
SG - Singapore 1.272
CN - Cina 1.215
GB - Regno Unito 998
IT - Italia 498
SE - Svezia 392
BR - Brasile 333
FR - Francia 282
HK - Hong Kong 270
VN - Vietnam 260
FI - Finlandia 235
DE - Germania 219
IE - Irlanda 209
KR - Corea 104
UA - Ucraina 68
IN - India 55
BD - Bangladesh 53
CA - Canada 48
TR - Turchia 40
AR - Argentina 38
JP - Giappone 33
BE - Belgio 30
MX - Messico 23
PL - Polonia 22
IQ - Iraq 20
NL - Olanda 20
ZA - Sudafrica 20
ES - Italia 18
EC - Ecuador 17
ID - Indonesia 16
NG - Nigeria 16
IR - Iran 14
PY - Paraguay 14
SA - Arabia Saudita 14
AT - Austria 12
CL - Cile 12
UZ - Uzbekistan 12
IL - Israele 11
AU - Australia 10
CZ - Repubblica Ceca 10
CH - Svizzera 9
CO - Colombia 9
MA - Marocco 9
PK - Pakistan 9
DK - Danimarca 8
GR - Grecia 7
JO - Giordania 7
DO - Repubblica Dominicana 6
EU - Europa 6
LT - Lituania 6
VE - Venezuela 6
AZ - Azerbaigian 5
DZ - Algeria 5
PH - Filippine 5
RO - Romania 5
TN - Tunisia 5
CR - Costa Rica 4
EG - Egitto 4
LV - Lettonia 4
AL - Albania 3
BG - Bulgaria 3
ET - Etiopia 3
JM - Giamaica 3
KG - Kirghizistan 3
MN - Mongolia 3
NI - Nicaragua 3
OM - Oman 3
PE - Perù 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AO - Angola 2
CI - Costa d'Avorio 2
HU - Ungheria 2
KE - Kenya 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
SN - Senegal 2
TG - Togo 2
UY - Uruguay 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
Totale 14.858
Salva come PNG Salva come JPEG
Città #
Southend 814
Singapore 710
Ashburn 681
Moscow 613
Chandler 611
San Jose 505
Dallas 450
Jacksonville 430
Woodbridge 410
Ann Arbor 301
Hong Kong 265
Dublin 209
Council Bluffs 198
Houston 194
Verona 193
Beijing 182
New York 151
The Dalles 120
Wilmington 98
Lawrence 89
Princeton 89
Los Angeles 87
Nanjing 85
Jinan 80
Helsinki 76
Hebei 74
Hanoi 65
Ho Chi Minh City 63
Shenyang 62
Buffalo 53
Orem 48
Tianjin 45
Santa Clara 44
Munich 41
Haikou 40
São Paulo 40
Changsha 39
Milan 38
Boardman 37
Ningbo 37
Columbus 33
Zhengzhou 32
Redondo Beach 30
Brussels 29
Taiyuan 28
Tokyo 28
Turku 28
Hangzhou 27
Lancaster 27
Washington 27
Nanchang 26
Taizhou 25
Fuzhou 24
Stockholm 24
Sindelfingen 22
Bologna 21
Guangzhou 21
Istanbul 21
Chennai 20
Redmond 20
Redwood City 20
Seattle 20
Atlanta 19
Brooklyn 18
Denver 18
Jiaxing 18
Montreal 17
Warsaw 17
Frankfurt am Main 16
Norwalk 16
Abuja 15
Auburn Hills 15
Da Nang 15
London 15
Poplar 15
Rome 15
Falls Church 14
Lanzhou 14
Boston 13
Johannesburg 13
Manchester 13
Phoenix 13
Belo Horizonte 12
Chicago 12
Düsseldorf 12
Haiphong 12
Seoul 12
Amsterdam 11
Clearwater 11
Paris 11
San Francisco 11
Tashkent 11
Baghdad 10
Cleveland 10
Dong Ket 10
Olomouc 10
Riva 10
Toronto 10
Kemerovo 9
Asunción 8
Totale 9.421
Salva come PNG Salva come JPEG
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 264
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 240
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 236
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 234
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 229
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 224
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 223
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 220
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 218
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 214
A case of acute fulminant multiple sclerosis treated with alemtuzumab 214
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 213
Cognitive onset in multiple sclerosis 210
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 210
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 208
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 208
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 206
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 206
COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk 199
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 195
Apporto della neurofisiologia allo studio delle disfunzioni dell'apparato uro-genitale 191
A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble? 190
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 190
Clinical and pathological correlations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: a cross-sectional morphometric and immunohistochemical study in twenty cases 188
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 188
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial 187
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 186
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 186
Effects of pulsed electromagnetic fields on nerve regeneration: an experimental study in the rat 185
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 184
Epilepsy in multiple sclerosis: The role of temporal lobe damage 184
Glial cell and macrophage reactions in rat spinal ganglion after peripheral nerve lesions: an immuno-cytochemical and morphometric study 182
Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population. 181
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 181
Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study 180
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 179
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 178
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 175
Myelin oligodendrocyte glycoprotein polymorphisms and multiple sclerosis. 174
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 174
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 173
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 171
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 169
Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis 168
A multicentric prospective incidence study of Guillain-Barré Syndrome in Italy. The ITANG Study 168
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 165
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 160
Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro 158
Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients. 158
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 154
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 151
Multifactorial etiological aspects of epilepsy 150
Epilessia ed imaging 150
Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients 150
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 150
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 149
Azathioprine in multiple sclerosis 148
Resting motor threshold in idiopathic generalized epilepsies: A systematic review with meta-analysis. 148
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 148
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 148
Prevalence of dementia and apoliprotein E genotype distribution in the elderly of Buttapietra, Verona Province, Italy 147
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 145
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 145
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 142
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 141
Long survival and clinical stability in Marburg's variant multiple sclerosis. 141
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis 141
Prognosi del Piccolo Male-assenze tipiche. Studio di follow-up su 60 casi. [Prognosis of pure petit mal. Follow-up study of 60 cases] 140
Short term prognosis of stroke in a clinical series of 94 patients 138
Prognosis of Epilepsy in Newly Referred Patients: A Multicenter Prospective Study of the Effects of Monotherapy on the Long‐Term Course of Epilepsy 133
Prognostic factors of acute partial transverse myelitis. 133
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study 132
Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. 129
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 128
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 126
Use of plasma levels for antiepileptic drug monitoring in clinical practice 126
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study 124
A Panel of Exploratory CSF Biomarkers in Patients with an Initial Demyelinating Event of the CNS: Does It Add Relevant Information to Usual Work-Up? (P02.080) 122
Efficacia della monoterapia in pazienti epilettici di nuova diagnosi e precedentemente non trattati. Studio prospettico 119
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study. 118
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives 118
Prognostic indicators of “benign” clinical course in multiple sclerosis patients. 115
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 111
Reappraisal of Aβ40 and Aβ42 Peptides Measurements in Cerebrospinal Fluid of Patients with Alzheimer's Disease 108
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial 106
Treatment strategies for multiple sclerosis: when to start, when to change, when to stop? 103
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. 97
Trial of minocycline in clinically isolated syndrome of Multiple Sclerosis 96
Multiple radiculopathy as the presenting manifestation of primary spinal leptomeningeal B cell lymphoma detected by flow cytometry of cerebrospinal fluid. 94
Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis 92
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. 91
Totale 14.971
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.824
article - articoli 48.148
book - libri 0
conference - conferenze 575
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.101
Totale 99.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022853 0 350 12 122 19 23 10 54 26 18 51 168
2022/20231.607 109 195 140 290 126 364 12 114 176 11 49 21
2023/2024860 30 72 83 85 101 195 26 78 6 33 90 61
2024/20251.832 95 128 104 288 111 71 93 72 252 97 152 369
2025/20265.945 408 266 486 920 1.574 372 531 265 511 344 91 177
2026/2027179 53 126 0 0 0 0 0 0 0 0 0 0
Totale 14.971